Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic
Most known driver genes of metastatic prostate cancer are frequently mutated. To dig into the long tail of rarely mutated drivers, we performed network-based driver identification on the Hartwig Medical Foundation metastatic prostate cancer data set (HMF cohort). Hereto, we developed GoNetic, a meth...
Saved in:
Main Authors: | Louise de Schaetzen van Brienen, Giles Miclotte, Maarten Larmuseau, Jimmy Van den Eynden, Kathleen Marchal |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d39ae633b1bc40268809f76d24f6dd91 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants
by: Paulina Maria Nawrocka, et al.
Published: (2021) -
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
by: Nikolai A. Ognerubov
Published: (2021) -
A Network-Centric Framework for the Evaluation of Mutual Exclusivity Tests on Cancer Drivers
by: Rafsan Ahmed, et al.
Published: (2021) -
Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era
by: Isaac E. Kim, et al.
Published: (2021) -
An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
by: Josephina P. M. Vrouwe, et al.
Published: (2021)